These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 26342321)
1. Preparation and pharmacodynamic assessment of ezetimibe nanocrystals: Effect of P-gp inhibitory stabilizer on particle size and oral absorption. Srivalli KMR; Mishra B Colloids Surf B Biointerfaces; 2015 Nov; 135():756-764. PubMed ID: 26342321 [TBL] [Abstract][Full Text] [Related]
2. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances. Srivalli KM; Mishra B AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622 [TBL] [Abstract][Full Text] [Related]
3. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe. Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288 [TBL] [Abstract][Full Text] [Related]
4. Dual drug nanocrystals loaded microparticles for fixed dose combination of simvastatin and ezetimibe. Nandi S; Kaur A; Bansal AK Pharm Dev Technol; 2020 Jan; 25(1):40-53. PubMed ID: 31524550 [TBL] [Abstract][Full Text] [Related]
5. Design and characterization of nanocrystal formulations containing ezetimibe. Gulsun T; Gursoy RN; Oner L Chem Pharm Bull (Tokyo); 2011; 59(1):41-5. PubMed ID: 21212545 [TBL] [Abstract][Full Text] [Related]
6. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals. Jain S; Patel K; Arora S; Reddy VA; Dora CP Drug Deliv Transl Res; 2017 Apr; 7(2):292-303. PubMed ID: 28116656 [TBL] [Abstract][Full Text] [Related]
7. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals. Liu Y; Wang Y; Zhao J Int J Biol Macromol; 2019 Mar; 124():667-680. PubMed ID: 30502425 [TBL] [Abstract][Full Text] [Related]
8. Dissolution rate enhancement of new co-crystals of ezetimibe with maleic acid and isonicotinamide. Wen L; Man Z; Yu-Zhen Y; Yan-Jie H; Xiao-Hui Z; Kai S; Ling F; Li Na D Pak J Pharm Sci; 2019 Jul; 32(4):1501-1507. PubMed ID: 31608868 [TBL] [Abstract][Full Text] [Related]
9. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. Jain S; Reddy VA; Arora S; Patel K Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488 [TBL] [Abstract][Full Text] [Related]
10. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size. Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239 [TBL] [Abstract][Full Text] [Related]
11. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182 [TBL] [Abstract][Full Text] [Related]
12. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability. Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466 [TBL] [Abstract][Full Text] [Related]
13. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Freag MS; Elnaggar YS; Abdallah OY Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765 [TBL] [Abstract][Full Text] [Related]
14. Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet. Agrawal YO; Mahajan UB; Agnihotri VV; Nilange MS; Mahajan HS; Sharma C; Ojha S; Patil CR; Goyal SN Molecules; 2021 Mar; 26(5):. PubMed ID: 33803259 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery. Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185 [TBL] [Abstract][Full Text] [Related]
16. New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin. Riekes MK; Engelen A; Appeltans B; Rombaut P; Stulzer HK; Van den Mooter G Pharm Res; 2016 May; 33(5):1259-75. PubMed ID: 26857899 [TBL] [Abstract][Full Text] [Related]
17. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Bandyopadhyay S; Katare OP; Singh B Expert Opin Drug Deliv; 2014 Apr; 11(4):479-92. PubMed ID: 24386966 [TBL] [Abstract][Full Text] [Related]
18. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Ige PP; Baria RK; Gattani SG Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990 [TBL] [Abstract][Full Text] [Related]
19. Enhanced water solubility, antioxidant activity, and oral absorption of hesperetin by D-α-tocopheryl polyethylene glycol 1000 succinate and phosphatidylcholine. Gu SF; Wang LY; Tian YJ; Zhou ZX; Tang JB; Liu XR; Jiang HP; Shen YQ J Zhejiang Univ Sci B; 2019 Mar.; 20(3):273-281. PubMed ID: 30829014 [TBL] [Abstract][Full Text] [Related]
20. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying. Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]